LFG
HQL

Larson Financial Group’s abrdn Life Sciences Investors HQL Stock Holding History

Larson Financial Group’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-429
Closed -$5.77K – 1846
2023
Q4 		$5.77K Hold
429
– – ﹤0.01% 1145
2023
Q3 		$5.35K Hold
429
– – ﹤0.01% 1155
2023
Q2 		$5.81K Hold
429
– – ﹤0.01% 1060
2023
Q1 		$5.98K Hold
429
– – ﹤0.01% 1048
2022
Q4 		$6.1K Hold
429
– – ﹤0.01% 992
2022
Q3 		$6K Hold
429
– – ﹤0.01% 916
2022
Q2 		$6K Hold
429
– – ﹤0.01% 828
2022
Q1 		$7K Hold
429
– – ﹤0.01% 729
2021
Q4 		$8K Buy
+429
New +$8.63K ﹤0.01% 724

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Larson Financial Group's HQL Position: Q1 2024 in Review

Larson Financial Group sold out of abrdn Life Sciences Investors (HQL) in Q1 2024, closing a stake of 429 shares — an estimated $5.77K sold.

Larson Financial Group first reported a position in HQL in Q4 2021 and held it in 9 quarters. The position peaked at $8K in Q4 2021. 79 funds tracked by Wall St. Rank hold HQL as of Q1 2024.

  • Larson Financial Group reported no remaining abrdn Life Sciences Investors position as of Q1 2024 after selling out during the quarter.
  • Larson Financial Group sold 429 abrdn Life Sciences Investors shares in Q1 2024, an estimated $5.77K.
  • Larson Financial Group first reported a position in abrdn Life Sciences Investors in Q4 2021 and held it in 9 quarters.
  • Larson Financial Group's abrdn Life Sciences Investors position peaked at $8K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2024.

Based on Larson Financial Group's 13F filing for Q1 2024, filed 3 May 2024.